PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Khasraw, M; Abrey, LE; Lassman, AB; Hormigo, A; Nolan, C; Gavrilovic, IT; Mellinghoff, IK; Reiner, AS; DeAngelis, L; Omuro, AM

Published Date

  • November 1, 2010

Published In

Volume / Issue

  • 12 /

Start / End Page

  • 72 - 72

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference

Conference Location

  • Hollywood, FL

Conference Start Date

  • December 9, 2010

Conference End Date

  • December 12, 2010